Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
about
Snakebite: When the Human Touch Becomes a Bad Touch.Epidemiology of snake bites in selected areas of KenyaIn vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodiesRevered but Poorly Understood: A Case Report of (Black Mamba) Envenomation in Watamu, Malindi Kenya, and a Review of the LiteratureThe paraspecific neutralisation of snake venom induced coagulopathy by antivenoms
P2860
Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@en
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@nl
type
label
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@en
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@nl
prefLabel
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@en
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@nl
P2093
P2860
P50
P1476
Preclinical antivenom-efficacy ...... ent capability in East Africa.
@en
P2093
Ana-Silvia Arias
Fiona Bolton
George O Oluoch
Hastings Ozwara
Jaffer Alsolaiss
José-María Gutiérrez
Paul Rowley
Stephen Kalya
P2860
P304
P356
10.1371/JOURNAL.PNTD.0005969
P407
P577
2017-10-18T00:00:00Z